Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta

Clinical trial NCT07366086 · RECRUITING

Trial details

NCT number: NCT07366086
Sponsor: Amgen
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Osteogenesis Imperfecta

Start date: 2026-03-18
Primary completion: 2028-04-19
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.